United States · Series A startup

Who invested in KayoThera

One round we have observed, with the 0 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$5.2Mraised across 1 round since 2023, from 1 source

Latest round
Series A, $5.2MJul 2023
Investors
0
See who backed them

The rounds

  1. Jul 2023
    Series A$5.2M

    No investor was named in the report.

    Source recordedSEC filing: $10M sold, first sale Mar 2022

Founders and team

From KayoThera's own website and the SEC filings it signed: 5 on the team.

  • Thong Q. LePresident and CEO
  • Ian HowesChief Financial Officer
  • Paul SekhriBoard Member
  • Kendall MohlerExecutive Officer, Directori
  • Mark EspositoExecutive Officer, Directori

Also claim to have backed them

This firm lists KayoThera as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

7G BioVenturesVC firmPer its own site

Quick answers about KayoThera

How much has KayoThera raised?

KayoThera has raised $5.2M across 1 round since 2023.

When did KayoThera last raise?

KayoThera's most recent round was a Series A of $5.2M in Jul 2023.

What was KayoThera's biggest round?

Its most recent round, $5.2M in Jul 2023, is also its largest on record.

What stage is KayoThera at?

KayoThera's latest named round is a Series A, in Jul 2023.

Where is KayoThera based?

KayoThera is based in the United States.

Companies like KayoThera

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.